Study to Assess the Safety and Efficacy of THR-18 When Administered to Patients Suffering Acute Ischemic Stroke and Treated With Tissue Plasminogen Activator (tPA)
- First Posted Date
- 2010-12-03
- Last Posted Date
- 2010-12-03
- Lead Sponsor
- Thrombotech Ltd.
- Target Recruit Count
- 22
- Registration Number
- NCT01253512
- Locations
- 🇮🇱
Hadassah Medical Center,, Jerusalem, Israel
© Copyright 2025. All Rights Reserved by MedPath